The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

The Effects of Injincheonggan-tang on Two Patients with HBeAg-Negative Chronic Hepatitis B : Case Report

  • Jang, Eun Gyeong (Department of International Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Young Chul (Department of International Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Woo, Hong Jung (Department of International Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Lee, Jang Hoon (Department of International Medicine, College of Korean Medicine, Kyung Hee University)
  • Received : 2014.04.15
  • Accepted : 2014.06.24
  • Published : 2014.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This case report was executed to confirm the efficacy and safety of Injincheonggan-tang on two patients with HBeAg-negative chronic hepatitis B. Methods: We reviewed the changes of clinical progress and laboratory records of patients with chronic hepatitis B who did not want to take any antiviral or interferon therapy. One patient has visited the department of internal medicine I of Kyung Hee University Korean Medicine Hospital, from October 2010 and the other, from October 2006. Both of them were prescribed with Injincheonggan-tang and laboratory tests were conducted as well. Results and Conclusions: AST, ALT and HBV DNA which are significant indicators of liver function were controlled in the normal range during the herbal treatment period and subjective clinical symptoms were also improved after taking Injincheonggan-tang.

Keywords

References

  1. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003;362:2089-94. https://doi.org/10.1016/S0140-6736(03)15108-2
  2. Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut. 1996;38(Suppl 2):S18-23. https://doi.org/10.1136/gut.38.Suppl_2.S18
  3. Redeker AG. Viral hepatitis:clinical aspects. Am J Med Sci. 1975;270:9-16. https://doi.org/10.1097/00000441-197507000-00003
  4. Yim HJ, Anna Suk-Fong Lok. Natural history of chronic hepatitis B virus infection : what we know in 1981 and what we know in 2005. Hepatology. 2006;43:S174.
  5. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis : incidence and risk factors. Gastroenterology. 2004;127 (Suppl 1):S35-S50. https://doi.org/10.1053/j.gastro.2004.09.014
  6. Lee JE, Kim CW, Jung YJ, Rhew KY, Kim YC, Lee JH, et al. Two Cases of Injinchunggan-tang Treated Patients with Chronic Hepatitis B Relapsed after Lamivudine Therapy. The Journal of Korean Oriental Internal Medicine. 2005;spr(1):230-39.
  7. Woo HJ, Lee JH, Kim SM. The Effect of Inchinchunggantang on inhibition of HBeAg production in HepG2.2.15 Cell line. Collection of dissertations of Korean medicine college of Kyung Hee university. 1998;21(1):171-9
  8. Kuo A, Gish R. Chronic Hepatitis B Infection. Clin Liver Dis. 2012;16:347-69. https://doi.org/10.1016/j.cld.2012.03.003
  9. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, et al. Prevalence of HBV Precore/Core Promoter Variants in the United States. Hepatology. 2003;38(3):619-28.
  10. McMahon BJ. Natural History of Chronic Hepatitis B Infection. Clin Liver Dis. 2010;14: 381-96. https://doi.org/10.1016/j.cld.2010.05.007